uvstocks.io

Today’s CSR movers

PEP 3.0 —

HLT 4.0 —

CPRT 3.9 —

XEL 4.8 —

CRL 4.0 —

ZTS 3.6 —

Health Care · NYSE NYSE · CRL

Charles River Laboratories

$306.24 +$4.29 +1.40% CLOSE 10.15.26 AFTER HOURS $306.24

Convergence score

4.0 / 5.0 STRONG BULLISH

+0.0 vs last report

Overall valuation

—

Aggregated across multiple horizons

Consensus target (12mo)

$311.13 +1.6%

Range $145.00 — $357.00

Sector

Health Care

NYSE · Tracked daily

Today's snapshot

Where the signals stand.

REPORT 10.15.26

UV Convergence Score

REPORT 10.15.26

4.0

/ 5.0

STRONG BULLISH

Consensus signal A

4.0

Consensus signal B

4.0

Consensus signal D

4.0

Analyst average

4.3

Multi-signal aggregate How CSR works →

Day Range

$295.51 – $309.48

52W Range

$146.20 – $333.30

Volume

919.5K

Avg Vol

945.3K

Mkt Cap

$14.62B

P/E

—

EPS (TTM)

—

Div Yield

0.00%

Beta

1.40

Today's convergence

Convergence score sits at 4.0 . Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation

—

CSR direction

STRONG BULLISH

Last close

$306.24

Sector

Health Care

Valuation

Three horizons

UPDATED 10.15.26

Short term

0–3 MO

No target —

Medium term

3–12 MO

$302-1.3% Buy

Long term

12–36 MO

No target —

Open valuation →

Analysts

Coverage & consensus

3 PANELS

Mean target (12mo)

$311.13 +1.6%

RANGE $145.00 — $357.00

Analyst consensus

Consensus rating Buy

Blended score 4.1 / 5

Analysts tracked 50

Open analysts →

Financials

Key metrics

LATEST

P/E

—

EPS (TTM)

—

Mkt Cap

$14.62B

Div Yield

0.00%

Beta

1.40

52W Range

$146.20 – $333.30

Open financials →

Reports

Valuation breakdown

Three horizons, one consensus.

UPDATED 10.15.26

Short term

0–3 MO

—

Consensus target

No target available

Medium term

3–12 MO

Buy

Consensus target

$302 -1.3%

RANGE $219 – $357

$219NOW $306.24$357

12-month analyst consensus target across covering brokerages.

Long term

12–36 MO

—

Consensus target

No target available

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0

Top-level breakdown

Valuation:	PE Ratio: -	PEG Ratio: -	DE Ratio: -
Free Cash Flow: $468.86M	PB Ratio: -	PS Ratio: -	Dividend: -

Analyst coverage

Blended analyst consensus & targets.

3 PANELS · UPDATED 10.15.26

Analyst consensus RATING · SCORE · PANELS · ANALYSTS

Rating Blended score Panels Analysts

Buy 4.1 3 50

Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE

Coverage Low Mean Median High Upside

All panels $145.00 $311.13 $330.00 $357.00 +1.6%

Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL

Coverage SB B H S SS

All panels 6 23 4 2 0

Rating trend CURRENT VS 1M / 2M / 3M

Period Rating Avg Analysts

Current — — —

1 Mo Ago — — —

2 Mo Ago — — —

3 Mo Ago — — —

Most recent analyst action LATEST DESK ACTION

Date

10/12/2026

Firm

Morgan Stanley

Action

Boost Target

Rating

Overweight

Target

$340.00

Full financial snapshot.

UPDATED 10.15.26

Quote snapshot 15 FIELDS

Prev Close

$302.00

Open

$301.81

Day Low

$295.51

Day High

$309.48

Bid

$306.25

Ask

$318.00

52W Low

$146.20

52W High

$333.30

50D Avg

$287.28

200D Avg

$214.09

Volume

919.5K

Avg Vol

945.3K

10D Avg Vol

983.2K

52W Change

72.62%

S&P 52W Change

16.44%

Valuation ratios 10 FIELDS

P/E (TTM)

—

P/E (Fwd)

24.00

PEG (Fwd)

0.12

P/S

3.66

P/B

5.15

Book Value

$59.50

EV/Revenue

4.38

EV/EBITDA

20.62

Mkt Cap

14.62B

Enterprise Val

17.51B

Profitability & returns 6 FIELDS

Profit Margin

-5.96%

Gross Margin

34.58%

Operating Margin

15.11%

EBITDA Margin

21.23%

Return on Assets

4.11%

Return on Equity

-7.52%

Growth 3 FIELDS

Revenue Growth (YoY)

-2.70%

Earnings Growth (YoY)

—

Earnings Growth (Q)

—

Balance sheet & cash flow 11 FIELDS

Total Revenue

EBITDA

849.12M

Total Cash

192.02M

Total Debt

3.03B

Cash / Share

$4.02

Revenue / Share

$81.86

Free Cash Flow

468.86M

Operating CF

582.15M

Debt / Equity

105.05

Current Ratio

1.35

Quick Ratio

0.80

Dividend 5 FIELDS

Fwd Dividend

—

Dividend Yield

0.00%

Payout Ratio

0.00%

5Y Avg Yield

—

Ex-Div Date

—

Share statistics 7 FIELDS

Shares Out

47.74M

Float

47.2M

Shares Short

2.88M

% Short of Float

6.97%

Short Ratio

3.02

% Held Insiders

0.47%

% Held Institutions

122.76%

Calendar & events 5 FIELDS

Next Earnings

2026-11-04

Fiscal Year End

2025-12-27

Most Recent Qtr

2026-06-27

Last Split

—

Split Date

—

Company 2 FIELDS

Industry

Diagnostics & Research

Employees

18,300